UNDA 243 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 243 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Boldo Leaf, Cholesterinum, Combretum micranthum, Lycopodium clavatum, Podophyllum peltatum
SUBSTANCE NAME: PEUMUS BOLDUS LEAF; CHOLESTEROL; COMBRETUM MICRANTHUM LEAF; LYCOPODIUM CLAVATUM SPORE; PODOPHYLLUM PELTATUM ROOT
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-09-29
END MARKETING DATE: 0000-00-00


UNDA 243 HUMAN OTC DRUG Details:

Item DescriptionUNDA 243 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 12; 4; 4; 4([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2015-09-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1162_5aa64b40-ffa9-3f0a-e053-2991aa0a55c8
PRODUCT NDC: 62106-1162
APPLICATION NUMBER:

Other PEUMUS BOLDUS LEAF; CHOLESTEROL; COMBRETUM MICRANTHUM LEAF; LYCOPODIUM CLAVATUM SPORE; PODOPHYLLUM PELTATUM ROOT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 243